0001493152-23-024899.txt : 20230719
0001493152-23-024899.hdr.sgml : 20230719
20230719120006
ACCESSION NUMBER: 0001493152-23-024899
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230712
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waldman Lawrence
CENTRAL INDEX KEY: 0001516592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31885
FILM NUMBER: 231096072
MAIL ADDRESS:
STREET 1: 5115 ULMERTON RD.
CITY: CLEARWATER
STATE: FL
ZIP: 33770
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apyx Medical Corp
CENTRAL INDEX KEY: 0000719135
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112644611
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5115 ULMERTON ROAD
CITY: CLEARWATER
STATE: FL
ZIP: 33760
BUSINESS PHONE: 7273842323
MAIL ADDRESS:
STREET 1: 5115 ULMERTON ROAD
CITY: CLEARWATER
STATE: FL
ZIP: 33760
FORMER COMPANY:
FORMER CONFORMED NAME: BOVIE MEDICAL Corp
DATE OF NAME CHANGE: 20150319
FORMER COMPANY:
FORMER CONFORMED NAME: BOVIE MEDICAL CORP
DATE OF NAME CHANGE: 19990216
FORMER COMPANY:
FORMER CONFORMED NAME: AN CON GENETICS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2023-07-12
0
0000719135
Apyx Medical Corp
APYX
0001516592
Waldman Lawrence
C/O APYX MEDICAL CORPORATION
5115 ULMERTON ROAD
CLEARWATER
FL
33760
1
0
0
0
0
Common Stock
2023-07-12
4
M
0
5338
2.97
A
5338
I
By SLAT
Common Stock
37563
D
Stock Option (Option to Buy)
2.97
2023-07-12
4
M
0
12000
0
D
2014-07-16
2023-07-16
Common Stock
12000
0
I
By SLAT
Represents a "net exercise" of outstanding stock options. The Reporting Person received 5,338 shares of common stock on net exercise of an option to purchase 12,000 shares of common stock.
The Reporting Person transferred this option to a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT.
The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.
/s/ Lawrence Waldman
2023-07-19